PharmacoEconomics

, Volume 2, Issue 1, pp 67–76

Healthcare Resource and Lost Labour Costs of Migraine Headache in the US

  • Jane T. Osterhaus
  • Donna L. Gutterman
  • John R. Plachetka
Original Research Article

Summary

Migraine headache is responsible for significantly more healthcare resource and lost labour costs than previously reported. Costs associated with migraine were assessed via a survey conducted in 940 patients, 70% of whom responded. All met the International Headache Society’s diagnostic criteria for migraine and had participated in one of two multicentre, single-dose, parallel-group, randomised, placebo-controlled clinical trials designed to assess the efficacy of an anti-migraine compound. Migraine frequency and costs, in terms of healthcare resource utilisation and lost labour (decreased productivity and missed workdays), were assessed. Over 90% of respondents visited a clinic and nearly 50% presented to an emergency room for treatment of migraine-related symptoms at least once in the year prior to the survey. These 648 respondents used an estimated $US529 199 per year in healthcare services. 89% of employed respondents reported that job performance was adversely affected by migraine and over 50% of them missed at least two days of work per month. Depending on the estimates used for migraine prevalence and using 1986 estimates of median earnings for the US work force, the extrapolated costs to employers ranged from $US5.6 billion to $US17.2 billion dollars annually due to decreased productivity and missed work days. The cost of migraine is not fully appreciated by the medical community or by society.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anon. Statistics, in SAS User’s Guide. Version 5. Cary, NC, SAS Institute Inc, 1985Google Scholar
  2. Anon. Average cost to community hospitals per patient 1970 to 1987, and average semi-private room charge, 1978–1987. Hospital Statistics. American Hospital Association, Chicago Illinois, in U.S. Bureau of the Census, Statistical Abstract no. 166 of the United States 1989, 109th ed., U.S. Government Printing Office, Washington, DC, 1989aGoogle Scholar
  3. Anon. Median money income of year-round full-time workers with income, by sex and age: 1970 to 1987, in U.S. Bureau of the Census. Statistical Abstract no. 727 of the United States 1989, 109th ed., U.S. Government Printing Office, Washington, DC, 1989bGoogle Scholar
  4. Anon. Full-time wage and salary workers—number and median weekly earnings, by selected characteristics: 1983 to 1987, in U.S. Bureau of the Census. Statistical Abstract no. 666 of the United States 1989, 109th ed., U.S. Government Printing Office, Washington, DC, 1989cGoogle Scholar
  5. Anon. Employer costs for employee compensation per hour worked, by industry, in U.S. Bureau of the Census. Statistical Abstract no. 670 of the United States 1989, 109th ed., U.S. Government Printing Office, Washington, DC, 1989dGoogle Scholar
  6. Anon. Prevalence of selected reported chronic conditions, by age and sex: 1980 and 1987, in U.S. Bureau of the Census. Statistical Abstract no. 190 of the United States 1989, 109th ed., U.S. Government Printing Office, Washington, DC, 1989eGoogle Scholar
  7. Anon. Civilian labour force: employment status by sex, race, and age: 1987, in U.S. Bureau of the Census. Statistical Abstract no. 625 of the United States 1989, 109th ed., U.S. Government Printing Office, Washington, DC, 1989fGoogle Scholar
  8. Benassi G, D’Alessandro R, Lenzi PL, Manzaroli D, Baldrati A, Lugaresi E. The economic burden of headache: an epidemiological study in the republic of San Marino. Headache 26: 457–459, 1986PubMedCrossRefGoogle Scholar
  9. Blau JN, Drummond HF. Migraine. Office of Health Economics, 1991Google Scholar
  10. Bruyn GW. Epidemiology of migraine’ a personal view’. Headache 23: 127–133, 1983PubMedCrossRefGoogle Scholar
  11. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H. Treatment of acute migraine with subcutaneous sumatriptan. Journal of the American Medical Association 265: 2831–2835, 1991PubMedCrossRefGoogle Scholar
  12. Centers for Disease Control. Prevalence of chronic migraine headaches — United States, 1980–1989. Morbidity and Mortality Weekly Report 40: 331–332, 1991Google Scholar
  13. Clarke GJ, Waters WE. Headache and migraine in a London general practice. In Waters E (Ed.) The epidemiology of migraine: six surveys of headache and migraine, pp. 14–22, Boehringer Ingelheim, Bracknell-Berkshire, 1974Google Scholar
  14. Espir MLE, Thomason J, Blau JN, Kurtz Z. Headaches in civil servants: effect on work and leisure. British Journal of Industrial Medicine 45: 336–340, 1988PubMedGoogle Scholar
  15. Fox N, Morton RE, Jacobs J. The cost-effectiveness of maintenance therapy for duodenal ulceration with an H2-antagonist. Alimentary Pharmacology and Therapeutics 2: 297–309, 1988PubMedCrossRefGoogle Scholar
  16. Green JE. Migraine abroad: a survey of migraine in England 1975-976. Headache 17: 67–68, 1977PubMedCrossRefGoogle Scholar
  17. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl. 7): 19–28, 1988Google Scholar
  18. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA. The economic costs of non-insulin dependent diabetes mellitus. Journal of the American Medical Association 262: 2708–2713, 1989PubMedCrossRefGoogle Scholar
  19. Jones A, Harrop C. Study of migraine and the treatment of acute attacks in industry. Journal of International Medical Research 8: 321–325, 1980PubMedGoogle Scholar
  20. Linet MS, Stewart WF. Migraine headache: epidemiological perspectives. Epidemiology Review 6: 107–139, 1984Google Scholar
  21. Nikiforow R, Hokkanen E. Effects of headache on working ability: survey of an urban and rural population in northern Finland. Headache 19: 214–218, 1979PubMedCrossRefGoogle Scholar
  22. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Journal of the American Medical Association 267: 64–69, 1992PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1992

Authors and Affiliations

  • Jane T. Osterhaus
    • 1
  • Donna L. Gutterman
    • 1
  • John R. Plachetka
    • 1
  1. 1.Glaxo Inc. Research InstituteResearch Triangle ParkUSA

Personalised recommendations